Development of an antimicrobial formulation for control of specimen-related contamination in phage-based diagnostic testing for tuberculosis

Abstract

Use of NOA antimicrobial supplement with rapid phage-based tests for TB will increase the proportion of interpretable results obtained, and enable their wider implementation in disease-endemic countries by improved control of specimen-related contamination.